Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095443
Filing Date
2024-08-12
Accepted
2024-08-12 16:14:20
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srzn-20240630.htm   iXBRL 10-Q 2154437
2 EX-31.1 srzn-ex31_1.htm EX-31.1 15429
3 EX-31.2 srzn-ex31_2.htm EX-31.2 15488
4 EX-32.1 srzn-ex32_1.htm EX-32.1 8481
5 EX-32.2 srzn-ex32_2.htm EX-32.2 8519
6 GRAPHIC img200701597_0.jpg GRAPHIC 46555
  Complete submission text file 0000950170-24-095443.txt   8446140

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20240630.xsd EX-101.SCH 1319396
72 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20240630_htm.xml XML 1319709
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39635 | Film No.: 241196951
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)